Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03812718
Other study ID # EC/01/19/1464
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 4, 2019
Est. completion date December 2024

Study information

Verified date April 2023
Source Sir Ganga Ram Hospital
Contact Nitin Sethi, DNB
Phone 00919717494498
Email nitinsethi77@yahoo.co.in
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endotracheal tube (ETT) is the gold standard conduit for providing controlled ventilation during general anaesthesia (GA). however, the supra-glottic airway (SGA) devices in particular the laryngeal mask airway (LMA) and its variants have become a reliable alternative to ETT for carrying out controlled ventilation. Of the several variants of LMA available today, the proseal LMA (PLMA) is preferred for controlled ventilation. The various advantages of LMA includes, a lower incidence of postoperative sore throat and superior haemodynamic profile during surgery. However, one aspect of providing anaesthesia with LMA compared to ETT is the ability of LMA to maintain equivalent depth of anaesthesia with lower anaesthetic requirement, is quiet intriguing and evidence to this regard is very limited. By measuring the anaesthesia requirement using a robust computerised delivery system such as the closed loop anaesthesia delivery system (CLADS) we can establish for sure the anaesthesia required for maintaining intraoperative mechanical ventilation with the use of these two (ETT and PLMA) airway management devices. This randomised controlled study aims to calculate the anaesthesia requirement as determined by the total amount of propofol consumed for maintaining anaesthesia with ETT versus PLMA


Description:

Endotracheal tube (ETT) is the gold standard conduit for providing controlled ventilation during general anesthesia (GA). However, since the introduction of classic laryngeal mask airway (LMA) in the 1980's and serial evolution of supra-glottic airway devices (SGA) thereafter, LMAs have become a reliable alternative to ETT for carrying out controlled ventilation. Interestingly, of the additional advantages that the LMA proffers, including, a lower incidence of postoperative sore throat (POST) and superior hemodyamic profile during surgery; its ability to maintain equivalent depth of anesthesia (in comparison to when ETT-GA) with lower anesthetic requirement, is intriguing. A handful of studies have demonstrated that the end-tidal isoflurane concentration required for maintenance of GA is 0.2 -0.53% greater with use of ETT as compared to LMA. However, the evidence generated by these studies remains unsubstantiated because in them, anaesthetic gas concentration was titrated to patient's clinical profile like heart rate and blood pressure without the backing of specific protocol for maintaining depth-of-anaesthesia. Therefore, for credible evidence, assessment of quantitative anesthetic requirement for achieving and sustaining a steady anesthesia depth with either LMA or ETT warrants confirmation with the use of an objective depth-of-anesthesia monitor, such as, bispectral index (BIS). Closed loop anaesthesia delivery system (CLADS) is an indigenously developed patented (502/DEL/2003) computer-controlled and BIS-guided automated anesthesia delivery system. CLADS, which runs on a control algorithm based on the relationship between diverse rates of propofol infusion and the processed EEG variable; delivers propofol infusion at a rate which is continuously adjusted by patient's state of depth of anesthesia as per BIS monitoring input. This automated system maintains anaesthesia depth with high accuracy and objectively determines propofol delivery quantitatively. Of the several variants of SGA available today, the ProSeal laryngeal mask airway (PLMA) 9 is preferred for controlled ventilation for its unique design that serves dual function of a ventilation tube and an oropharyngeal drainage tube for excluding gastric contents from getting aspirated through the peri-laryngeal cuff seal. Given that CLADS can help us to accurately quantify anaesthesia, we hypothesize that there is no difference in anesthesia requirement for GA maintained through an ETT or a PLMA. This randomized controlled study aims to compare: anaesthesia requirement as determined by total propofol consumption (primary objective); intraoperative hemodynamic profile and incidence of POST (secondary objectives) in patients undergoing laparoscopic surgery with controlled ventilation via ETT or PLMA.


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. ASA physical status I/II 2. Undergoing elective laparoscopic cholecystectomy Exclusion Criteria: 1. Anticipated difficult airway 2. Body mass index > 30-kg/m2 3. Uncompensated cardiovascular disease (e.g. uncontrolled hypertension, atrio-ventricular block, sinus bradycardia, congenital heart disease, reduced LV compliance, diastolic dysfunction) 4. Hepato-renal insufficiency 5. Uncontrolled endocrinology disease (e.g. diabetes mellitus, hypothyroidism) 6. Known allergy/hypersensitivity to the study drug (propofol) 7. Drug dependence/substance abuse/psychiatric illness 8. Requirement of postoperative ventilation 9. Refusal to informed consent

Study Design


Intervention

Device:
Endotracheal tube (ETT)
After induction of anaesthesia patient will be intubated with polyvinyl chloride (PVC) ETT for maintaining intraoperative ventilation. Anaesthesia will be maintained with propofol and the administration rate will be controlled by a feedback loop facilitated by BIS monitoring using the closed-loop anaesthesia delivery system (CLADS). A BIS value of 50 will be used as the target point for induction and maintenance of GA.
ProSeal Laryngeal Mask Airway (PLMA)
After induction of anaesthesia ProSeal Laryngeal Mask Airway (PLMA) will be inserted for maintaining intraoperative ventilation. Anaesthesia will be maintained with propofol and the administration rate will be controlled by a feedback loop facilitated by BIS monitoring using the closed-loop anaesthesia delivery system (CLADS). A BIS value of 50 will be used as the target point for induction and maintenance of GA.

Locations

Country Name City State
India Sir Ganga Ram Hospital New Delhi Delhi

Sponsors (1)

Lead Sponsor Collaborator
Sir Ganga Ram Hospital

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Propofol usage in milligrams Comparison of quantitative difference in propofol requirement between the two groups From beginning of anaesthesia (0-hours, baseline) till 4 hours intraoperatively
Secondary Anaesthesia depth consistency using BIS scores Determined by the percentage of the total anaesthesia time in which the BIS scores remain within a score of 10% of the target BIS (i.e. BIS-50) in both the study arms. From beginning of anaesthesia (0-hours, baseline) till 3 hours intraoperatively
Secondary Evaluation of propofol anaesthesia delivery system Determined by using Varvel criteria parameters; median performance error (MDP), median absolute performance error (MDAPE), wobble and global score in both the study arms From beginning of anaesthesia (0-hours, baseline) till 3 hours intraoperatively
Secondary Change in Intra-operative heart Rate (beats per minute) Comparison of intra-operative heart rate between both the arms will be done From beginning of anaesthesia (0-hours, baseline) till 3 hours intraoperatively
Secondary Change in Intra-operative systolic , diastolic, and mean (mmHg) Comparison of intra-operative blood pressure- systolic, diastolic, and mean between both the arms will be done From beginning of anaesthesia (0-hours, baseline) till 10 hours intraoperatively
Secondary Early Recovery from anesthesia Time taken by the patient to open his/her eyes after discontinuation of anaesthesia will be noted From end of anaesthesia till 20-minutes postoperatively
Secondary Post operative sedation Will be assessed using Modified Observer's assessment of alertness/sedation scale (MOAA/S) From the end of anaesthesia till 24-hours, postoperatively
Secondary Incidence of postoperative sore throat Comparison of post operative sore throat occurrence between the two groups From the end of anaesthesia till 24-hours, postoperatively
See also
  Status Clinical Trial Phase
Terminated NCT01552421 - The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative Course N/A
Completed NCT01056250 - SILS Cholecystectomy: Cholangiography of the Biliary Tract N/A
Completed NCT00974194 - Safety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies N/A
Completed NCT00940264 - Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection. N/A
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Recruiting NCT06045546 - A (5-5-5-8) Technique for Laparoscopic Cholecystectomy N/A
Recruiting NCT06036303 - Nasr Fascial Closure: A Novel Device for Fascial Closure in Laparoscopic Surgery N/A
Recruiting NCT06035302 - Madany Closure: A Novel Technique for Fascial Closure in Laparoscopic Surgery N/A
Completed NCT01824186 - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT00209885 - Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Phase 4
Completed NCT02116985 - Dual-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy (DLTCI) Phase 4
Completed NCT00161083 - UDCA for Symptomatic Gallstone Disease Phase 4
Recruiting NCT05280860 - Effect of Bilateral RSB on Postoperative Delirium in Elderly Patients Undergoing Laparoendoscopic Single-site Surgery N/A
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Completed NCT03154164 - Study on the Learning Curve for Fundus First With Ultrasonic Tissue Coagulation in Elective Cholecystectomy
Recruiting NCT02114437 - Closed-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy Phase 4
Completed NCT01553331 - Day Case Laparoscopic Cholecystectomy: Fundus First With Ultrasonic Dissection or Conventional Diathermy Hook N/A
Recruiting NCT03909360 - Drainage or Not for Laparoscopic Cholecystetomy N/A
Recruiting NCT05962853 - Effect of TENS on Patient Outcomes After Laparoscopic Cholecystectomy: A Randomized Controlled Study N/A
Recruiting NCT05723224 - Elective Endoscopic Gallbladder Treatment: Pilot Study N/A